Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CorMedix (CRMD) Net Cash Flow: 2010-2024

Historic Net Cash Flow for CorMedix (CRMD) over the last 14 years, with Dec 2024 value amounting to -$3.1 million.

  • CorMedix's Net Cash Flow fell 1729.66% to -$109.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.1 million, marking a year-over-year increase of 153.55%. This contributed to the annual value of -$3.1 million for FY2024, which is 787.85% down from last year.
  • CorMedix's Net Cash Flow amounted to -$3.1 million in FY2024, which was down 787.85% from $445,639 recorded in FY2023.
  • In the past 5 years, CorMedix's Net Cash Flow registered a high of $25.6 million during FY2020, and its lowest value of -$10.2 million during FY2022.
  • Its 3-year average for Net Cash Flow is -$4.3 million, with a median of -$3.1 million in 2024.
  • In the last 5 years, CorMedix's Net Cash Flow spiked by 2,115.45% in 2020 and then plummeted by 787.85% in 2024.
  • Over the past 5 years, CorMedix's Net Cash Flow (Yearly) stood at $25.6 million in 2020, then slumped by 55.13% to $11.5 million in 2021, then plummeted by 188.67% to -$10.2 million in 2022, then skyrocketed by 104.38% to $445,639 in 2023, then slumped by 787.85% to -$3.1 million in 2024.